Select Publications
Preprints
, 2025, The GLP-1 RA boom: Trends in publicly subsidised and private access in Australia, 2020-2025, http://dx.doi.org/10.1101/2025.10.30.25339120
, 2025, The association between low-grade proteinuria and adverse kidney outcomes in IgA nephropathy: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2025.08.12.25333541
, 2024, Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis, http://dx.doi.org/10.1101/2024.03.28.24305010
, 2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, http://dx.doi.org/10.1101/2023.06.26.23291881
, 2023, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, http://dx.doi.org/10.1101/2023.06.18.23290762
, 2019, EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (Preprint), http://dx.doi.org/10.2196/preprints.15646